Tim I. Muller
Sigmund Freud Str. 25
Bonn, NW 53127, Germany
Bonn, NW 53127, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
A pH-Tolerant Nickel-Vanadium Phosphonate Framework for Stable Aqueous Supercapacitor Cycling.
Journal: ACS nano
Published: July 06, 2026
ShadowVIMP: permutation-based multiple testing-controlled variable selection.
Journal: BMC bioinformatics
Published: August 07, 2025
Effects of Concurrent Training on Resuscitation and Cognitive Performance in Paramedics-A Pilot Study.
Journal: Healthcare (Basel, Switzerland)
Published: July 15, 2024
Space hardware for concrete sample production on ISS "MASON concrete mixer".
Journal: NPJ microgravity
Published: December 22, 2022
Programmed Cell Death Ligand-1 (PDL-1) Correlates With Tumor Infiltration by Immune Cells and Represents a Promising Target for Immunotherapy in Endometrial Cancer.
Journal: Anticancer research
Published: October 29, 2021
Karyopherin Alpha 2 Is an Adverse Prognostic Factor in Clear-Cell and Papillary Renal-Cell Carcinoma.
Journal: Clinical genitourinary cancer
Published: June 18, 2018
The Mediator complex subunit MED15, a promoter of tumour progression and metastatic spread in renal cell carcinoma.
Journal: Cancer biomarkers : section A of Disease markers
Published: February 06, 2018
The knockdown of the mediator complex subunit MED30 suppresses the proliferation and migration of renal cell carcinoma cells.
Journal: Annals of diagnostic pathology
Published: November 02, 2017
The knockdown of the Mediator complex subunit MED15 restrains urothelial bladder cancer cells' malignancy.
Journal: Oncology letters
Published: September 15, 2017
The Contrasting Role of the Mediator Subunit MED30 in the Progression of Bladder Cancer.
Journal: Anticancer research
Published: August 30, 2017
PD-L1 (CD274) and PD-L2 (PDCD1LG2) promoter methylation is associated with HPV infection and transcriptional repression in head and neck squamous cell carcinomas.
Journal: Oncotarget
Published: May 31, 2017
PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma.
Journal: Oncotarget
Published: December 14, 2016
Last Updated: 09/26/2026